Epidemiology of sexually transmitted infections

References

• World Health Organisation. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. WHO, Geneva, Switzerland (2001).
   Google Scholar
• Ezzati M, Lopez AD, Rodgers A et al. Selected major risk factors and global and regional burden of disease. Lancet360, 1347–1360 (2002).
   PubMed Web of Science ®Google Scholar
• White PJ, Ward H, Cassell JA et al. Vicious and virtuous circles in the dynamics of infectious disease and the provision of health care: gonorrhea in Britain as an example. J. Infect. Dis.192, 824–836 (2005).
   PubMed Web of Science ®Google Scholar
• Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet359, 881–884 (2002).
   PubMed Web of Science ®Google Scholar
• Fenton K, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex. Transm. Infect.80, 255–263 (2004).
   PubMed Web of Science ®Google Scholar
• Van de Heyden JH, Catchpole MA, Paget WJ, Stroobant A. Trends in gonorrhea in nine western European countries, 1991–1996: European Study Group. Sex. Transm. Infect.76, 110–116 (2000).
   PubMed Web of Science ®Google Scholar
• Cronberg S. The rise and fall of sexually transmitted infections in Sweden. Genitourin. Med.69, 184–186 (1993).
   PubMedGoogle Scholar
• Chesson HW, Dee TS, Aral SO. AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sex. Transm. Dis.30, 419–424 (2003).
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. Annual Report: A Complex Picture. Health Protection Agency, London, UK (2006).
   Google Scholar
• Idahl A, Boman J, Kumlin U et al. Demonstration of Chlamydia trachomatis IgG antibodies in the male partner of the infertile couple is correlated with a reduced likelihood of achieving pregnancy. Hum. Reprod.19, 1121–1126 (2004).
   PubMed Web of Science ®Google Scholar
• Bakken-Inger J, Nordbø-Svein A, Skjeldestad-Finn E. Chlamydia trachomatis testing patterns and prevalence of genital chlamydial infection among young men and women in central Norway 1990–2003: a population-based registry study. Sex. Transm. Dis.33, 26–30 (2006).
   PubMed Web of Science ®Google Scholar
• Vajdic CM, Middleton M, Bowden FJ et al. The prevalence of genital Chlamydia trachomatis in Australia 1997–2004: a systematic review. Sex. Health2, 169–183 (2005).
   Google Scholar
• Paget WJ, Zbinden R, Ritzler E et al. National laboratory reports of Chlamydia trachomatis seriously underestimate the frequency of genital chlamydial infections among women in Switzerland. Sex. Transm. Dis.29, 715–720 (2002).
   PubMed Web of Science ®Google Scholar
• Department of Health. New Frontiers: Annual Report of the National Chlamydia Screening Programme in England 2005/06. Department of Health, London, UK (2006).
   Google Scholar
• LaMontagne DS, Fenton KA, Randall S et al. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex. Transm. Infect.80, 335–341 (2004).
   PubMed Web of Science ®Google Scholar
• LaMontagne DS, Baster K, Emmett L et al. Incidence and re-infection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by The Chlamydia Recall Study Advisory Group. Sex. Transm. Infect.83, 292–303 (2007).
   PubMed Web of Science ®Google Scholar
• Burckhardt F, Warner P, Young H. What is the impact of change in diagnostic test method on surveillance data trends in Chlamydia trachomatis infection? Sex. Transm. Infect.82, 24–30 (2006).
   PubMed Web of Science ®Google Scholar
• Pimenta JM, Catchpole M, Rogers PA et al. Opportunistic screening for genital Chlamydia infection II: prevalence amongst healthcare attenders, outcome, and evaluation of positive cases. Sex. Transm. Infect.79, 22–27 (2003).
   PubMed Web of Science ®Google Scholar
• Pimenta JM, Catchpole M, Rogers PA et al. Opportunistic screening for genital Chlamydia infection I: acceptability of urine testing in primary and secondary healthcare settings. Sex. Transm. Infect.79, 16–21 (2003).
   PubMed Web of Science ®Google Scholar
• Turner KME, Adams EJ, LaMontagne DS, Emmett L, Baster K, Edmunds WJ. Modelling the effectiveness of Chlamydia screening in England. Sex. Transm. Infect.82, 496–502 (2006).
   PubMed Web of Science ®Google Scholar
• Low N, Egger M, Sterne JAC et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women’s Cohort Study. Sex. Transm. Infect.82, 212–218 (2006).
   PubMed Web of Science ®Google Scholar
• Chen MY, Fairley CK, Donovan B. Discordance between trends in Chlamydia notifications and hospital admission rates for Chlamydia related diseases in New South Wales, Australia. Sex. Transm. Infect.81, 318–322 (2005).
   PubMed Web of Science ®Google Scholar
• Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N. Engl. J. Med.334, 1362–1366 (1996).
   PubMed Web of Science ®Google Scholar
• Kamwendo F, Forslin L, Bodin L, Danielsson D. Programmes to reduce pelvic inflammatory disease – the Swedish experience. Lancet351(Suppl. 3), 25–28 (1998).
   PubMed Web of Science ®Google Scholar
• Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital Chlamydia infections: a meta-analysis of randomized clinical trials. Sex. Transm. Dis.29, 497–502 (2002).
   PubMed Web of Science ®Google Scholar
• Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet351(Suppl. 3), 5–7 (1998).
   PubMed Web of Science ®Google Scholar
• Turner KME, Garnett GP, Ghani AC, Sterne JAC, Low N. Investigating ethnic inequalities in the incidence of sexually transmitted infections: mathematical modelling study. Sex. Transm. Infect.80, 379–385 (2004).
   PubMed Web of Science ®Google Scholar
• WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria Gonorrhoeae in the WHO Western Pacific Region, 2004. Commun. Dis. Intell.30, 129–132 (2006).
   Google Scholar
• Health Protection Agency. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Annual Report Year 2005 Collection. Health Protection Agency, London, UK (2006).
   Google Scholar
• Tapsall JW. Antibiotic resistance in Neisseria gonorrheae. Clin. Infect. Dis.41, S263–S268 (2005).
   PubMedGoogle Scholar
• McClelland RS, Sangare L, Hassan WM et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J. Infect. Dis.195, 698–702 (2007).
   PubMed Web of Science ®Google Scholar
• Pickering JM, Whitworth JAG, Hughes P et al. Aetiology of sexually transmitted infections and response to syndromic treatment in southwest Uganda. Sex. Transm. Infect.81, 488–493 (2005).
   PubMed Web of Science ®Google Scholar
• Bowden FJ. Was the Papanicolaou smear responsible for the decline of Trichomonas vaginalis? Sex. Transm. Infect.79, 263 (2003).
   PubMedGoogle Scholar
• Miller WC, Swygard H, Hobbs MM et al. The prevalence of trichomoniasis in young adults in the United States. Sex. Transm. Dis.32, 592–598 (2005).
   Google Scholar
• Seña AC, Miller WC, Hobbs MM et al.Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin. Infect. Dis.44, 13–22 (2007).
   PubMed Web of Science ®Google Scholar
• Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob. Agents. Chemother.50, 4209–4210 (2006).
   Google Scholar
• Cotch MF, Pastorek JG, Nugent RP et al.Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex. Transm. Dis.24, 353–360 (1997).
   PubMed Web of Science ®Google Scholar
• Kigozi GG, Brahmbhatt H, Wabwire-Mangen F et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am. J. Obstet. Gynecol.189, 1398–1400 (2003).
   PubMed Web of Science ®Google Scholar
• Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet. Gynecol.105, 857–868 (2005).
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson D, Horner PJ. The role of Mycoplasma genitalium in non-gonococcal urethritis. Sex. Transm. Infect.77, 229–331 (2001).
   PubMed Web of Science ®Google Scholar
• Falk L, Fredlund H, Jensen JS. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis. Sex. Transm. Infect.80, 289–293 (2004).
   PubMed Web of Science ®Google Scholar
• Anagrius C, Lore B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex. Transm. Infect.81, 458–462 (2005).
   PubMed Web of Science ®Google Scholar
• Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet359, 765–766 (2003).
   Web of Science ®Google Scholar
• Bradshaw CS, Jensen JS, Tabrizi SN et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerging Infect. Dis.12, 1149–1152 (2006).
   PubMed Web of Science ®Google Scholar
• Maeda-Shin I, Deguchi T, Ishiko H et al. Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasmaparvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in patients with non-gonococcal urethritis using polymerase chain reaction-microtiter plate hybridization. Int. J. Urol.11, 750–754 (2004).
   PubMed Web of Science ®Google Scholar
• Zdrodowska SB, Klosowska WM, Ostaszewska PI et al.Mycoplasma hominis and Ureaplasma urealyticum infections in male urethritis and its complications. Adv. Med. Sci.51, 254–257 (2006).
   PubMedGoogle Scholar
• Deperthes BD, Meheus A, O’Reilly K, Broutet N. Maternal and congenital syphilis programmes: case studies in Bolivia, Kenya and South Africa. Bull. World Health Organ.82, 410–416 (2004).
   PubMed Web of Science ®Google Scholar
• Miranda AE, Alves MC, Neto RL et al. Seroprevalence of HIV, hepatitis B virus, and syphilis in women at their first visit to public antenatal clinics in Vitoria, Brazil. Sex. Transm. Dis.28, 710–713 (2001).
   PubMed Web of Science ®Google Scholar
• Temmerman M, Gichangi P, Fonck K et al. Effect of a syphilis control programme on pregnancy outcome in Nairobi, Kenya. Sex. Transm. Infect.76, 117–121 (2000).
   PubMed Web of Science ®Google Scholar
• Ahmed HJ, Mbwana J, Gunnarsson E et al. Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two Tanzanian cities. Sex. Transm. Dis.30, 115–119 (2003).
   Google Scholar
• Sanchez J, Volquez C, Totten PA et al. The etiology and management of genital ulcers in the Dominican Republic and Peru. Sex. Transm. Dis.29, 559–567 (2002).
   PubMed Web of Science ®Google Scholar
• Risbud A, Chan-Tact K, Gadkari D et al. The etiology of genital ulcerative disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted diseases clinics in Pune, India. Sex. Transm. Dis.16, 55–65 (1999).
   Google Scholar
• Chen-Zhi Q, Zhang-Guo C, Gong-Xiang D et al. Syphilis in China: results of a national surveillance programme. Lancet369, 132–138 (2007).
   PubMed Web of Science ®Google Scholar
• Peterman TA, Furness BW. The resurgence of syphilis among men who have sex with men. Curr. Opin. Infect. Dis.20(1), 54–59 (2007).
   PubMed Web of Science ®Google Scholar
• Bauwens JE, Orlander H, Gomez MP et al. Epidemic Lymphogranuloma venereum during epidemics of crack cocaine use and HIV infection in the Bahamas. Sex. Transm. Dis.29, 253–259 (2002).
   PubMed Web of Science ®Google Scholar
• Weiss HA, Thomas SL, Munabi SK, Hayes RJ. Male circumcision and the risk of syphilis, chancroid and genital herpes: a systematic review and meta-analysis. Sex. Transm. Infect.82, 101–109 (2006).
   PubMed Web of Science ®Google Scholar
• Steen R. Eradicating chancroid. Bull. World Health Organ.79, 818–826 (2001).
   PubMed Web of Science ®Google Scholar
• O’Farrell N. Donovanosis. Sex. Transm. Infect.78, 452–457 (2002).
   PubMed Web of Science ®Google Scholar
• Bowden FJ. Donovanosis in Australia: going, going. Sex. Transm. Infect.81, 365–366 (2005).
   PubMed Web of Science ®Google Scholar
• Gottlieb M, Schroff R, Schanker H et al.Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular deficiency. N. Engl. J. Med.305, 1425–1431 (1981).
   PubMed Web of Science ®Google Scholar
• Chermann J, Barre-Sinoussi F, Dauguet C et al. Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. Antibiot. Chemother.32, 48–53 (1983).
   PubMedGoogle Scholar
• UNAIDS. AIDS Epidemic Update 2006. UNAIDS, Switzerland 2006.
   Google Scholar
• Schmid GP, Buve A, Mugyenyi P et al. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet363, 482–488 (2004).
   PubMed Web of Science ®Google Scholar
• Gisselquist D, Potterat JJ, Brody S. Running on empty: sexual co-factors are insufficient to fuel Africa’s turbocharged HIV epidemic. Int. J. STD AIDS15(7), 442–452 (2004).
   PubMed Web of Science ®Google Scholar
• Gisselquist D, Rothenberg R, Potterat J, Druckner E. HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission. Int. J. STD AIDS13(10), 657–666 (2002).
   PubMed Web of Science ®Google Scholar
• French K, Riley S, Garnett G. Simulations of the HIV epidemic in sub-Saharan Africa: sexual transmission versus transmission through unsafe medical injections. Sex. Transm. Dis.33, 127–134 (2006).
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Update on HIV/AIDS in the European Region: Ensuring Universal Access to Prevention, Treatment, Care and Support Services. WHO Regional Office for Europe, Geneva, Switzerland (2006).
   Google Scholar
• McCutchan FE. Global epidemiology of HIV. J. Med. Virol.78, S7–S12 (2006).
   PubMed Web of Science ®Google Scholar
• van der Loeff MFS, Awasana AA, Sarge NR et al. Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2. Int. J. Epidemiol.35(5), 1322–1328 (2006).
   PubMed Web of Science ®Google Scholar
• Valadas E, Antunes F. HIV-2: the Portuguese connection. Clin. Infect. Dis.39(10), 1553–1554 (2004).
   PubMed Web of Science ®Google Scholar
• Schim van der Loeff M, Aaby P. Towards a better understanding of the epidemiology of HIV-2. AIDS13, S69–S84 (1999).
   Google Scholar
• Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect.75, 3–17 (1999).
   PubMed Web of Science ®Google Scholar
• Wawer MJ, Gray RH, Sewankambo et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis.191(9), 1403–1409 (2005).
   PubMed Web of Science ®Google Scholar
• Reynolds SJ, Risbud AR, Shepherd ME et al. High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India. Sex. Transm. Infect.82, 121–126 (2006).
   PubMed Web of Science ®Google Scholar
• Korenromp EL, White RG, Orroth KK et al. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J. Infect. Dis.191, S168–S178 (2005).
   PubMed Web of Science ®Google Scholar
• Soriano V, Sulkowski M, Bergin C et al. Care of patients with chronic hepatitis C, HIV co-infection: recommendations from the HIV–HCV International Panel. AIDS16, 813–828 (2002).
   PubMed Web of Science ®Google Scholar
• Poynard T, Mathurin P, Lai-Ching L et al. A comparison of fibrosis progression in chronic liver diseases. J. Hepatol.38, 257–265 (2003).
   PubMed Web of Science ®Google Scholar
• Puoit M, Bruno R, Soriano V et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS18, 2285–2293 (2004).
   PubMed Web of Science ®Google Scholar
• Geretti AM. Epidemiology of antiretroviral drug resistance in drug-naïve persons. Curr. Opin. Infect. Dis.20(1), 22–32 (2007).
   PubMed Web of Science ®Google Scholar
• Shet A, Berry L, Mohri H et al. Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience. J. Acquir. Immune Defic. Syndr.41(4), 439–446 (2006).
   PubMed Web of Science ®Google Scholar
• UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study and UK Register of HIV Seroconverters. Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom. AIDS21, 1035–1039 (2007).
   PubMed Web of Science ®Google Scholar
• Townsend CL, Cliffe S, Tookey PA. Uptake of antenatal HIV testing in the United Kingdom: 2000–2003. J. Public Health (Oxf.)28, 248–252 (2006).
   PubMed Web of Science ®Google Scholar
• Gray RH, Li X, Kigozi G et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet366, 1182–1188 (2005).
   PubMed Web of Science ®Google Scholar
• World Health Organisation. HIV/AIDS Surveillance in Europe: End-Year Report 2005, No. 73. WHO Regional Office for Europe, Geneva, Switzerland (2006).
   Google Scholar
• World Health Organisation. CISID – the Computerized Information System for Infectious Diseases. WHO Regional Office for Europe, Geneva, Switzerland (2006).
   Google Scholar
• Kozlov AP, Shaboltas AV, Toussova OV et al. HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS20, 901–906 (2006).
   PubMed Web of Science ®Google Scholar
• Kerr C. Injection drug use fuels HIV/AIDS epidemic across Eurasia. Lancet Infect. Dis.5, 539 (2005).
   PubMed Web of Science ®Google Scholar
• Kelly JA, Amirkhanian YA. The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe. Int. J. STD AIDS14, 361–371 (2003).
   PubMed Web of Science ®Google Scholar
• Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex. Transm. Dis.30, 797–800 (2003).
   PubMed Web of Science ®Google Scholar
• Haddow LJ, Dave B, Mindel A et al. Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003. Sex. Transm. Infect.82, 255–259 (2006).
   PubMed Web of Science ®Google Scholar
• Johnson AM, Mercer CH, Erens B et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet358, 1835–1842 (2001).
   PubMed Web of Science ®Google Scholar
• Wald A, Zeh J, Selke S et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N. Engl. J. Med.342, 844–850 (2000).
   PubMed Web of Science ®Google Scholar
• Whitley R. Neonatal herpes simplex virus infection. Curr. Opin. Infect. Dis.17(3), 243–246 (2004).
   PubMed Web of Science ®Google Scholar
• Mahnert N, Roberts SW, Laibl VR, Sheffield JS, Wendel GD. The incidence of neonatal herpes infection. Am. J. Obstet. Gynecol.196(5), e55–e56 (2007).
   PubMed Web of Science ®Google Scholar
• Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N. Engl. J. Med.341, 1432–1438 (1999).
   PubMed Web of Science ®Google Scholar
• Pebody RG, Andrews N, Brown D et al. The seroepidemiology of herpes simplex virus 1 and 2 in Europe. Sex. Transm. Infect.80, 185–191 (2004).
   PubMed Web of Science ®Google Scholar
• Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK. Herpes simplex virus type 2 in United States, 1976 to 1994. N. Eng. J. Med.337, 1105–1111 (1997).
   PubMed Web of Science ®Google Scholar
• Smith J, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus 2 and 1: a global review. J. Infect. Dis.186(Suppl. 1), S3–S28 (2002).
   PubMed Web of Science ®Google Scholar
• Theng TSC, Sen PR, Tan HH, Wong ML, Chan KWR. Seroprevalence of HSV-1 and -2 among sex workers attending a sexually transmitted infection clinic in Singapore. Int. J. STD AIDS17, 395–399 (2006).
   PubMed Web of Science ®Google Scholar
• Freeman EE, Weiss HA, Glynn JR et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS20, 73–83 (2006).
   PubMed Web of Science ®Google Scholar
• Ramjee G, Williams B, Gouws E et al. The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J. Acquir. Immune Defic. Syndr.39, 333–339 (2005).
   PubMed Web of Science ®Google Scholar
• Reynolds SJ, Risbud AR, Shepherd ME et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J. Infect. Dis.187, 1513–1521 (2003).
   PubMed Web of Science ®Google Scholar
• Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis.185, 45–52 (2002).
   PubMed Web of Science ®Google Scholar
• Gray RH, Wawer MJ, Brookmeyer R et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet357, 1149–1153 (2001).
   PubMed Web of Science ®Google Scholar
• Schacker T, Zeh J, Hu H et al. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J. Infect. Dis.186, 1718–1725 (2002).
   PubMed Web of Science ®Google Scholar
• Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med. Microbiol. Immunol.193, 35–44 (2003).
   PubMed Web of Science ®Google Scholar
• Garland SM, Hernandez AM, Wheeler CM et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med.356, 1928–1943 (2007).
   PubMed Web of Science ®Google Scholar
• Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect. Dis. Obstet. Gynecol.14, 404–407 (2006).
   Google Scholar
• Stone KM, Karem KL, Sternberg MR et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J. Infect. Dis.186, 1396–1402 (2002).
   PubMed Web of Science ®Google Scholar
• Dunne EF, Nielson CM, Stone KM et al. Prevalence of HPV infection in men: a systematic review of the literature. J. Infect. Dis.194, 1044–1057 (2006).
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Harris R, Sedjo RL et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women’s Health Study. J. Infect. Dis.186, 462–469 (2002).
   PubMed Web of Science ®Google Scholar
• Clarke P, Ebel C, Catotti DN et al. The psychosocial impact of human papillomavirus infection: implications for health care providers. Int. J. STD AIDS7, 197–200 (1996).
   PubMed Web of Science ®Google Scholar
• Watts DH, Koutsky LA, Holmes KK et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am. J. Obstet. Gynecol.178, 365–373 (1998).
   PubMed Web of Science ®Google Scholar
• Aldara™, package insert. 3M Pharmaceuticals, MN, USA (2005).
   Google Scholar
• Struve J, Giesecke J, Lindh G et al. Heterosexual contact as a major route of transmission for acute hepatitis B among adults. J. Infect.20, 111–121 (1990).
   PubMed Web of Science ®Google Scholar
• Brook MG. Sexually acquired hepatitis. Sex. Transm. Infect.78(4), 235–240 (2002).
   PubMed Web of Science ®Google Scholar
• Clarke A, Kulasegaram R. Hepatitis C transmission – where are we now? Int. J. STD AIDS17, 74–80 (2006).
   PubMedGoogle Scholar
• Brejt N, Gilleece Y, Fisher M. Acute hepatitis C: changing epidemiology and association with HIV infection. J. HIV Ther.12, 3–6 (2007).
   PubMedGoogle Scholar
• World Health Organisation. Weekly Epidemiological Record. No. 49, 10 December 1999. WHO, Geneva, Switzerland (1999).
   Google Scholar
• Frank C, Mohamed MK, Strickland GT et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet355, 887–891 (2000).
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. Hepatitis C in England: The Health Protection Agency Annual Report 2006. London, UK (2006).
   Google Scholar
• Health Protection Agency. Shooting Up. Infections Among Intravenous Drug Users in the UK 2005: An Update 2006. London, UK (2006).
   Google Scholar
• Matheï C, Buntinx F, van Damme P. Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. J. Viral Hepat.9, 157–173 (2002).
   PubMed Web of Science ®Google Scholar
• Hollinger FB, Liang TJ. Hepatitis B virus. In: Fields Virology (4th Edition). Knipe DM et al. (Eds). Lippincott Williams & Wilkins, PA, USA, 2971–3036 (2001).
   Google Scholar